Online citations, reference lists, and bibliographies.
← Back to Search

Peptidylarginine Deiminase 2, 3 And 4 Have Distinct Specificities Against Cellular Substrates: Novel Insights Into Autoantigen Selection In Rheumatoid Arthritis

E. Darrah, A. Rosen, J. Giles, F. Andrade
Published 2012 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Objective To define the relationship between autoantigen citrullination and different peptidylarginine deiminase (PAD) enzymes in rheumatoid arthritis (RA). Methods Citrullinated autoantigens were identified by immunoblotting control and ionomycin-activated human primary neutrophil lysate with RA sera. Autoantigen identity and citrullination sites were defined by mass spectrometry. PAD isoenzyme expression in human neutrophils was determined by immunoblotting. PAD substrate specificity was addressed in HL-60 cell lysates co-incubated with human recombinant PAD2, PAD3 and PAD4. Results Although prominent protein citrullination is observed in ionomycin-activated neutrophils, RA sera only recognised a limited number of these citrullinated molecules. Among these, the authors identified that β and γ-actins are citrullinated on at least 10 arginine residues, generating a novel 47 kDa species that is frequently recognised by RA autoantibodies. Interestingly, the authors showed that the PAD enzymes expressed in human neutrophils (ie, PAD2, PAD3 and PAD4) have unique substrate specificities, independent of their subcellular distribution. Thus, only PAD2 was able to citrullinate native β/γ-actin, while histone H3 was only citrullinated by PAD4. Conclusion These studies identified β and γ-actins as novel citrullinated autoantigens in RA, allowing enzyme specificity against intracellular substrates to be addressed. The studies provide evidence that PAD enzymes have the intrinsic capacity to select unique protein targets. The authors propose that unique PAD specificity may play a role in autoantigen selection in RA.
This paper references
10.1038/ng1206
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
A. Suzuki (2003)
10.1136/ARD.2003.012211
Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
E. Vossenaar (2004)
10.1186/ar2644
Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes
V. Goëb (2009)
10.1016/J.BBRC.2004.11.152
Comparison of enzymatic properties between hPADI2 and hPADI4.
Makiko Nakayama-Hamada (2005)
10.1002/ART.22983
Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation.
C. Foulquier (2007)
10.1002/art.23936
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
K. Lundberg (2008)
10.1002/art.23596
Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.
M. L. Harris (2008)
10.1189/jlb.70.1.46
Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils
H. Asaga (2001)
Functional haplotypes of PADI 4 , encoding citrullinating enzyme peptidylarginine deiminase 4 , are associated with rheumatoid arthritis
A. Suzuki (2003)
Specifi city and mode of action of the muscletype proteinarginine deiminase
K Nomura (1992)
10.1002/art.23618
Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
Andrew J Kinloch (2008)
10.1186/ar1149
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
E. Vossenaar (2004)
10.1002/art.27439
Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation.
F. Andrade (2010)
10.1093/RHEUMATOLOGY/KEH414
Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
X. Chang (2005)
10.1146/ANNUREV.BB.21.060192.000405
Structure and function of actin.
W. Kabsch (1992)
10.1074/jbc.M208795200
Nuclear Localization of Peptidylarginine Deiminase V and Histone Deimination in Granulocytes*
K. Nakashima (2002)
10.1172/JCI1316
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
G. A. Schellekens (1998)
10.1515/BC.2009.019
Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4
M. Stensland (2009)
10.1016/0003-9861(92)90407-N
Specificity and mode of action of the muscle-type protein-arginine deiminase.
K. Nomura (1992)
10.1021/bi100363t
Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
B. Knuckley (2010)
The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.
E. Girbal-Neuhauser (1999)
10.1002/prca.200900088
MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen
M. Hermansson (2010)
10.1016/J.BBRC.2005.12.160
Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis.
Y. Okazaki (2006)
10.1136/ard.2005.044743
Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids
Y. Takizawa (2006)
10.1136/ard.2008.091355
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles
O. Snir (2009)
10.1016/J.BBRC.2005.05.137
Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis.
A. Suzuki (2005)
10.1038/365810A0
The structure of crystalline profilin–β-actin
C. Schutt (1993)
This information is current as Inflammatory Stimuli in Neutrophils Histone Deimination As a Response to
Indira Neeli (2008)
10.1002/BIES.10357
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
E. Vossenaar (2003)
10.1038/nsmb799
Structural basis for Ca2+-induced activation of human PAD4
K. Arita (2004)
10.1186/ar1845
Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis
Andrew J Kinloch (2005)
10.1016/S0074-7696(01)02003-4
Functional specificity of actin isoforms.
S. Khaitlina (2001)
10.1073/PNAS.0509639103
Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
K. Arita (2006)
The structure of crystalline profi linbetaactin
CE Schutt (1993)
10.1021/JM0701932
Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis.
M. L. Pérez (2007)
10.1523/JNEUROSCI.3349-06.2006
Increased Citrullination of Histone H3 in Multiple Sclerosis Brain and Animal Models of Demyelination: A Role for Tumor Necrosis Factor-Induced Peptidylarginine Deiminase 4 Translocation
F. Mastronardi (2006)
10.1186/ar2085
Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach
K. Matsuo (2006)
10.1111/j.0105-2896.2009.00850.x
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
Natalia Wegner (2010)
10.1002/eji.200526000
Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis
H. Burkhardt (2005)



This paper is referenced by
10.3390/cells8090979
Neutrophil Extracellular Traps: Current Perspectives in the Eye
Gibrán Alejandro Estúa-Acosta (2019)
10.1016/B978-0-323-31696-5.00056-5
Chapter 56 – Autoantibodies in Rheumatoid Arthritis
F. Andrade (2017)
10.1007/978-1-4614-8317-5_3
The Role of Synovial Citrullinated Proteins in the Pathophysiology of Rheumatoid Arthritis
J. V. Beers (2014)
10.1002/art.41196
Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin‐Induced Cell Damage
V. Romero (2020)
10.1016/j.cbi.2018.06.016
Hydroquinone exposure worsens the symptomatology of rheumatoid arthritis.
C. Heluany (2018)
Peptidylarginine deiminase inhibitors regulate autophagy of human cancer cells and inflammation response of immune cells
S. Wang (2014)
10.23937/2378-3656/1410016
Outcomes of Influence of Dimethylarginine Derivats, PAD Isoenzymes, or both as Hallmark on Citrullinisation Process on Autoantigens ACPA/ Anti CCP Antibodies overall for Diagnosis in Rheumatoid Arthritis
Dejan Spasovski (2015)
10.5451/unibas-006288234
Neutrophil extracellular traps in inflammatory disorders
C. S. Chowdhury (2014)
10.3390/ijms21165720
The Essential Role of Peptidylarginine Deiminases 2 for Cytokines Secretion, Apoptosis, and Cell Adhesion in Macrophage
H. Yu (2020)
Smoking is associated with increased levels of extracellular peptidylarginine deiminase 2 (PAD2) in the lungs.
D. Damgaard (2015)
10.1158/1541-7786.MCR-16-0034
Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis
Neus Cantariño (2016)
10.2174/1389450116666150202160954
Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.
Erin E. Witalison (2015)
10.3389/fimmu.2018.02696
Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
E. Darrah (2018)
Modulation of chemokine function during inflammation
C. Barker (2014)
The Evolution of Ophthalmology in Rhode Island.
M. Migliori (2016)
10.1074/mcp.R113.033746
Methods for the Detection of Peptidylarginine Deiminase (PAD) Activity and Protein Citrullination*
S. Hensen (2013)
10.1080/1744666X.2020.1668778
Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine
L. Martinez-Prat (2019)
10.3390/ijms21072634
Identification and Characterization of the Lactating Mouse Mammary Gland Citrullinome
G. Li (2020)
10.1136/annrheumdis-2012-201906
Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts
O. Sánchez-Pernaute (2013)
10.1016/j.jim.2013.12.008
Generation of monoclonal antibodies against peptidylarginine deiminase 2 (PAD2) and development of a PAD2-specific enzyme-linked immunosorbent assay.
D. Damgaard (2014)
10.7555/JBR.33.20190075
Contribution of neutrophils in the pathogenesis of rheumatoid arthritis.
L. Zhang (2019)
10.3899/jrheum.120751
Screening Citrullinated Proteins in Synovial Tissues of Rheumatoid Arthritis Using 2-dimensional Western Blotting
X. Chang (2013)
10.1016/j.bmc.2017.03.006
Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis.
Amit Sarswat (2017)
10.1186/s13075-016-1126-7
Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans
Iris Navarro-Millán (2016)
10.1016/j.jaut.2017.01.006
Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
M. Bawadekar (2017)
10.1016/j.ddtec.2012.06.002
Peptidylarginine deiminases: physiological function, interaction with chemokines and role in pathology.
E. Moelants (2012)
10.1177/0961203314560005
Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses
F. Pratesi (2015)
10.3390/ijms18061196
Peptidylarginine Deiminases—Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
S. Lange (2017)
10.1016/j.bbamcr.2014.02.018
Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase–AIF pathway
Kin Pong U (2014)
10.3389/fimmu.2016.00328
NETosis – Does It Really Represent Nature’s “Suicide Bomber”?
S. Yousefi (2016)
10.1097/BOR.0000000000000452
Rheumatoid arthritis and citrullination
E. Darrah (2018)
10.1126/scitranslmed.3006869
Immune-Mediated Pore-Forming Pathways Induce Cellular Hypercitrullination and Generate Citrullinated Autoantigens in Rheumatoid Arthritis
V. Romero (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar